Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

PSA remains best indicator of prostate cancer progression

13.09.2005


Despite recent claims by some urologists that measuring the blood protein prostate-specific antigen (PSA) may not be effective in predicting risk of prostate cancer, a Johns Hopkins study of more than 2,000 men confirms that PSA remains the best measure of the likelihood of cancer recurrence after surgery.



Results of the study, published in the October issue of The Journal of Urology, demonstrated that men with high PSA levels prior to prostate removal surgery were significantly more likely to have advanced clinical stages of cancer, evidence of higher grade cancers in surgically removed tissue, and spread of cancer cells beyond the prostate. In addition, increasing PSA was significantly associated with increased risk of cancer recurrence after surgery, even in men with lower PSA levels prior to surgery.

The study was led by Stephen J. Freedland, M.D., clinical instructor of urology, and Alan W. Partin, M.D., Ph.D., professor and chair of urology at Johns Hopkins’ Brady Urological Institute.


"In our study, PSA levels measured before prostate removal surgery were significantly associated with the risk of recurrent cancer after surgery," Freedland says. "These data support the notion that PSA remains the best available prostate cancer tumor marker. It certainly suggests that the PSA era is alive and well."

PSA is a protein produced by cells of the prostate gland. Prostate cancer can increase PSA, so the higher the PSA level, the greater the likelihood that a patient has prostate cancer. Also, higher PSA values generally reflect larger, more aggressive cancers. Freedland acknowledges that because PSA provides physicians with a measure of a patient’s prostate health at a single point in time, it’s "far from perfect." However, he says, "it’s better than anything else we have."

"As a screening tool, PSA has done what we wanted it to do," Freedland says. "It detects advanced disease early and reduces the likelihood of metastatic disease."

For the study, Freedland and colleagues reviewed patient records for 2,312 men who had prostate removal surgery at Johns Hopkins between 1992 and 2004. All operations were performed by Patrick C. Walsh, M.D., professor and former chair of urology. The research team compared the association between preoperative PSA and the risk of cancer recurrence after surgery.

During an average follow-up of five years, 211 men (10 percent) had signs of recurrent cancer. Higher PSA levels prior to surgery were significantly associated with increased risk of cancer after surgery. Compared to men with PSA levels less than 10 nanograms per milliliter, men with PSA values between 10 and 19.9 nanograms per milliliter were more than three times more likely to develop cancer after surgery. Men with PSA levels of 20 nanograms per milliliter or greater were more than five times more likely to develop cancer after surgery than those with low PSA levels.

Even in men with PSA values of less than 10 nanograms per milliliter, increasing PSA was significantly associated with increased risk of cancer after surgery. For each two-point increase in PSA, the risk of cancer after surgery approximately doubled.

"From our study and others, it is clear that a single PSA value is an extremely useful measure of a patient’s risk of progression after surgery," Freedland says. "However, looking at how quickly the PSA increases over time is likely to be even more informative than a single value."

Eric Vohr | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>